Effects of human adipose-derived stem cells on the viability of rabbit random pattern flaps

Cytotherapy

Volumn 16, Issue 4, 2014, Pages 496-507

  Gong, Lunli ^a   Wang, Chen ^a   Li, Yarong ^b   Sun, Qingzhang ^c   Li, Guangzao ^c   Wang, Danru ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b WUXI APPTEC   (China)

^c BENGBU MEDICAL COLLEGE   (China)

Author keywords

Adipose derived stem cells; Immunomodulatory; Random pattern flap; Vascularization; Xenogenic transplantation

Indexed keywords

INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADIPOSE DERIVED STEM CELL TRANSPLANTATION; ADULT; ANIMAL EXPERIMENT; ARTICLE; CAPILLARY; CD4 CD8 RATIO; CELL HOMING; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOM PATTERN FLAP; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TISSUE FLAP;

ORYCTOLAGUS CUNICULUS;

ADIPOSE-DERIVED STEM CELLS; IMMUNOMODULATORY; RANDOM PATTERN FLAP; VASCULARIZATION; XENOGENIC TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GRAFT SURVIVAL; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; STEM CELL TRANSPLANTATION; STEM CELLS; SURGICAL FLAPS;

EID: 84895813231     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.11.005     Document Type: Article

References (40)

1. Nakajima H., Fujino T., Adachi S. A new concept of vascular supply to the skin and classification of skin flaps according to their vascularization. Ann Plast Surg 1986, 16:1-19.
2. Landmesser U., Hornig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109(Suppl 1):II27-II33.
3. Tepper O.M., Galiano R.D., Kalka C., Gurtner G.C. Endothelial progenitor cells: the promise of vascular stem cells for plastic surgery. Plast Reconstr Surg 2003, 111:846-854.
4. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
5. Butler D.L., Goldstein S.A., Guilak F. Functional tissue engineering: the role of biomechanics. J Biomech Eng 2000, 122:570-575.
6. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
7. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
8. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
9. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
10. Cui L., Wu Y., Cen L., Zhou H., Yin S., Liu G., et al. Repair of articular cartilage defect in non-weight bearing areas using adipose derived stem cells loaded polyglycolic acid mesh. Biomaterials 2009, 30:2683-2693.
11. Hausman G.J., Richardson R.L. Adipose tissue angiogenesis. J Anim Sci 2004, 82:925-934.
12. Cao Y., Sun Z., Liao L., Meng Y., Han Q., Zhao R.C. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005, 332:370-379.
13. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
14. Planat-Benard V., Silvestre J.S., Cousin B., André M., Nibbelink M., Tamarat R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109:656-663.
15. Prunet-Marcassus B., Cousin B., Caton D., André M., Pénicaud L., Casteilla L. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 2006, 312:727-736.
16. Dobson D.E., Kambe A., Block E., Dion T., Lu H., Castellot J.J., et al. 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell 1990, 61:223-230.
17. Claffey K.P., Wilkison W.O., Spiegelman B.M. Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992, 267:16317-16322.
18. Sierra-Honigmann M.R., Nath A.K., Murakami C., García-Cardeña G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
19. Nakagami H., Maeda K., Morishita R., Iguchi S., Nishikawa T., Takami Y., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005, 25:2542-2547.
20. Miranville A., Heeschen C., Sengenès C., Curat C.A., Busse R., Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110:349-355.
21. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
22. Strem B.M., Zhu M., Alfonso Z., Daniels E.J., Schreiber R., Beygui R., et al. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 2005, 7:282-291.
23. Cui L., Yin S., Liu W., Li N., Zhang W., Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007, 13:1185-1195.
24. Cui L., Liu B., Liu G., Zhang W., Cen L., Sun J., et al. Repair of cranial bone defects with adipose derived stem cells and coral scaffold in a canine model. Biomaterials 2007, 28:5477-5486.
25. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van Griensven M., Stadler G., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007, 13:1173-1183.
26. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
27. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
28. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
29. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002, 35:1010-1021.
30. Strem B.M., Hicok K.C., Zhu M., Wulur I., Alfonso Z., Schreiber R.E., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005, 54:132-141.
31. Kim W.S., Park B.S., Sung J.H., Yang J.M., Park S.B., Kwak S.J., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007, 48:15-24.
32. Behzadian M.A., Wang X.L., Al-Shabrawey M., Caldwell R.B. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia 1998, 24:216-225.
33. Patel B., Khaliq A., Jarvis-Evans J., McLeod D., Mackness M., Boulton M. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 1994, 34:639-644.
34. Bompais H., Chagraoui J., Canron X., Crisan M., Liu X.H., Anjo A., et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004, 103:2577-2584.
35. Kopp H.G., Ramos C.A., Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 2006, 13:175-181.
36. Aicher A., Rentsch M., Sasaki K., Ellwart J.W., Fändrich F., Siebert R., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007, 100:581-589.
37. Miettinen M., Lindenmayer A.E., Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994, 7:82-90.
38. Middleton J., Americh L., Gayon R., Julien D., Mansat M., Mansat P., et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005, 206:260-268.
39. Bar M., Sandmaier B.M., Inamoto Y., Bruno B., Hari P., Chauncey T., et al. Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant 2013, 19:949-957.
40. Niemeyer P., Vohrer J., Schmal H., Kasten P., Fellenberg J., Suedkamp N.P., et al. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 2008, 10:784-795.